Login

Healthcare

00:00:00
Cellmid expanding products, portfolio and markets - Maria Halasz , CEO, Cellmid Ltd
00:00:00
Development of a mobile system for managing type 1 diabetes - Eric Beard, Chairman and CEO of Cellnovo Group
00:00:00
Cello Health 'making good headway' with decent organic growth - Mark Scott, chief executive of Cello Health plc
00:00:00
Cerenis Therapeutics is specialized in research & development into HDL - Jean-Louis Dasseux, President and CEO of Cerenis Therapeutics
00:00:00
Checkpoint Therapeutics aiming to be phase 3 ready - James F. Oliviero President & Chief Executive Officer, Checkpoint Therapeutics Inc
00:00:00
Cipher Pharmaceuticals (TSX: CPH) Update with Craig Mull - CEO, Cipher Pharmaceuticals Inc
00:00:00
Commercialization of unique therapeutic products in adjunctive cancer care with a focus on infectious diseases. - Leonard Mazur, CEO, Citius Pharmaceuticals
00:00:00
CEO TALK - Yakov Kogan, CEO, Cleveland BioLabs
00:00:00
Eduardo Baviera Sabater, CEO, Clinica Baviera
00:00:00
Interview with Dan Mogren, CEO - Clinical Laserthermia Systems
00:00:00
An overview of Cocrystal’s core technology and applications in development - JAMES J. MARTIN Co-Chief Executive Officer and Chief Financial Officer, Cocrystal Pharma Inc
00:00:00
Emerging class of drugs for the treatment of chronic and age-related diseases - JOSEPH J. SARRET, M.D., J.D. Chief Executive Officer and Director, CohBar Inc
00:00:00
Release financial number showing more strong sales numbers - Jamal Rushdy, Chief Executive Officer, Collagen Solutions PLCC
00:00:00
DR. DAVID BURTON Executive Chairman, CEO, Compumedics Ltd
00:00:00
Talk about the company's joint venture to expand Positron Emission Tomography (PET)S - teven J. Mento, CEO, Conatus Pharmaceuticals
00:00:00
Jianyu Yang Chairman of the Board and Chief Executive Officer, Concord Medical Services Holdings Ltd

© 2017 - Townhall + Tv